Composition:
Glycopyrronium, Formoterol Fumarate and Budesonide Powder for Inhalation 25 mcg, 12 mcg and 400 mcg
Indication:
for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. This combination of medications is used to improve lung function, reduce symptoms such as shortness of breath, and decrease the frequency of COPD exacerbations.